Fatal lactic acidosis associated with highly active antiretroviral therapy in patients with advanced human immunodeficiency virus infection in Taiwan

International Journal of STD and AIDS

Volumn 15, Issue 4, 2004, Pages 249-253

  Sheng, W H ^a   Hsieh, S M ^a   Lee, S C ^b   Chen, M Y ^a   Wang, J T ^a   Hung, C C ^a,c   Chang, S C ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acquired immunodeficiency syndrome; Antiretroviral therapy; HIV infection; Lactic acidosis; Mitochondrial toxicity; Nucleoside reverse transcriptase inhibitor

Indexed keywords

AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; BODY MASS; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DYSPNEA; EPIGASTRIC PAIN; FATALITY; FEMALE; FEVER; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LABORATORY TEST; LACTIC ACIDOSIS; LIPODYSTROPHY; LYMPHOCYTE COUNT; MALE; MITOCHONDRIAL TOXICITY; MITOCHONDRION; MYOSITIS; NAUSEA; PANCREATITIS; PATIENT SELECTION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SHOCK; SIDE EFFECT; TAIWAN; TREATMENT OUTCOME; VOMITING;

ACID-BASE IMBALANCE; ACIDOSIS, LACTIC; ADULT; AGED; ALANINE TRANSAMINASE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BICARBONATES; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; DYSPNEA; FATTY LIVER; FEMALE; HIV INFECTIONS; HUMANS; LIPODYSTROPHY; MALE; MIDDLE AGED; MYOSITIS; NAUSEA; PANCREATITIS; PERIPHERAL NERVOUS SYSTEM DISEASES; REVERSE TRANSCRIPTASE INHIBITORS; VOMITING;

EID: 2342481118     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646204773557785     Document Type: Article

References (30)

1. Chattha G, Arieff AI, Cummings C, Tierney LM Jr. Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 1993;118:37-9
2. Madias NE. Lactic acidosis. Kidney Int 1986;29:752-74
3. Parker WP, Cheng YC. Mitochondrial toxicity of antiviral nucleoside analogs. J NIH Research 1994;6:57-61
4. Brinkman K, ter Hofstede HJM, Burger DM, Smeitink J, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998;12:1735-44
5. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999;354:1084-9
6. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8
7. Fouty B, Frerman F, Reves R. Riboflavin to treat nucleoside analogue induced lactic acidosis. Lancet 1998;352:291-2
8. Fortgang IS, Belitsos PC, Chaisson RE, Moore RD. Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. Am J Gastroenterol 1995;90:1433-6
9. ter Hofstede HJM, de Marie S, Foudraine NA, Danner SA, Brinkman K. Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy - 4 fatal cases. Int J STD AIDS 2000;11:611-16
10. Maulin L, Gerard Y, de la Tribonniere X, et al. Emerging complication of antiretroviral therapy - symptomatic hyperlactatemia [abstract 1285]. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, January 20-February 2, 1999
11. Falco V, Rodriguez D, Ribera E, et al. Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients - report of 12 cases and review of the literature. Clin Infect Dis 2002;34:838-42
12. Hung CC, Chen MY, Hsieh SM, Sheng WH, Chang SC. Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan - a 5-year prospective study. J Acquir Immun Defic Syndr 2000;24:378-85
13. Sundar K, Suarez M, Banogon PE, Shapiro JM. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. Crit Care Medá 1997;25:1425-30
14. Olano JP, Borucki MJ, Wen JW, Haque AK. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin Infect Dis 1995;21:973-6
15. Chen CH, Vazquez-Padua M, Cheng YC. Effect of antihuman immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol 1991;39:62-58
16. Carr A, Miller J, Law M, Cooper DA. A syndrome of lipodystrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 2000;14:F25-32
17. Lonergan JT, Behling C, Pfander H, Hassanein TI, Mathews WC. Hyperlactaemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens. Clin Infect Dis 2000;31:162-6
18. Stein DS. A new syndrome of hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS Clin Care 1994;6:17-21
19. Bissuel F, Bruneel F, Habersetzer F, et al. Fulminant hepatitis with severe lactic acidosis in HIV-infected patients on didanosine therapy. J Intern Med 1994;235:367-71
20. Gerard Y, Maulin L, Yazdanpanah, et al. Symptomatic hyperlactactaemia: an emerginig complication of antiretroviral therapy. AIDS 2000;14:2723-30
21. John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ, Mallal SA. Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS 2001;15:717-23
22. Lenzo NP, Garas BA, French MA. Hepatic steatosis and lactic acidosis associated with stavudine treatment in a HIV patient: a case report. AIDS 1997;11:1294-6
23. Gradon JD, Chapnick EK, Sepkowitz DV. Zidovudine-induced hepatitis. J Intern Med 1992;231:3171-8
24. Baram D, Cooke J. Lactic acidosis and AIDS [letter]. Ann Intern Med 1993;119:34-5
25. Aggarwal A, al-Talib K, Alabrash M. Type B lactic acidosis in an AIDS patient treated with zidovudine. Md Med J 1996;45:929-31
26. Charton-Bain MC, Flamant M, Aubertin JM, et al. Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine. Gastroenterol Clin Biol 1997;21:979-81
27. Chariot P, Drogou I, de Lacroix-Szmania I, et al. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J Hepatol 1999;30:156-60
28. Acosta BS, Grimsley EW. Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient. South Med J 1999;92:421-3
29. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996;335:1081-90
30. Delta Coordinating Committee. A randomized double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1996;348:283-91